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Poisoning gradeAbstract Background: Paraoxonase (PON1) is an A-esterase capable of hydrolyzing the active
metabolites (oxons) of many organophosphorus (OP) insecticides. Human PON1 displays two
polymorphisms in the coding region (Q192R and L55M) and several polymorphisms in the pro-
moter and the 30-UTR regions. Animal studies have shown that PON1 is an important determinant
of OP toxicity though a direct satisfactory veriﬁcation in humans is still lacking.
Aim: To investigate the impact of polymorphisms in the PON1 coding region (Q192R and
L55M) on individual sensitivity to OP poisoning.
Subjects and methods: This study enrolled 42 subjects (21 females and 21 males, age range 1.5–
53 years) diagnosed of acute OP poisoning. They were classiﬁed into 4 grades according to
manifestations. All subjects were genotyped for the PON1 gene polymorphisms; Q192R and
L55M using RFLP-PCR, then genotype frequencies were compared between different OP grades.
Results: Genotype frequency distribution of PON1 L55M polymorphism among different OP
poisoning grades revealed no signiﬁcant difference (p> 0.05) between the four grades. In contrast,
frequency distribution of PON1 Q192R polymorphism showed a highly signiﬁcant (p< 0.001)
difference between different grades of OP poisoning, with QQ genotype predominating in grade
4 with a frequency of 66.7%, followed by QR genotype (33.3%), while the RR and QR genotypes
were similarly distributed in grade 1 with a frequency of 50% for each.
Conclusion: The current results suggest a possible association between QQ genotype and poor
OP poisoning prognosis.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Pesticides represent a large and important class of environmen-
tal chemicals, and are often associated with adverse health
effects in non-target species including humans. Among the
major classes of pesticides, the insecticides are of most concern
with regard to potential adverse effects on the nervous system.
A major class of insecticides is represented by the organophos-
phates (OP), triesters of phosphoric acid that exert their
toxicity primarily by inhibiting the enzyme acetylcholinesterase
(AChE) [1]. OPs undergo bioactivation and detoxiﬁcation
processes that can be affected by genetic polymorphisms in
biotransformation enzymes. As numerous genetic variants
exist for all these enzymes, such genetic differences can greatly
inﬂuence the toxicity and neurotoxicity of OPs. Paraoxonase
(PON1), is a polymorphic enzyme that is involved in the detox-
iﬁcation of several important OPs. Paraoxonase takes its name
from the ability to hydrolyze paraoxon (PO), the highly toxic
metabolite of the insecticide parathion. Other OP substrates
of PON1 include chlorpyrifos oxon (CPO) and diazoxon
(DZO), the active metabolites of chlorpyrifos and diazinon,
respectively, as well as the nerve agents sarin, soman and VX
[2].
Early studies examining plasma paraoxonase levels in
human populations revealed a polymorphic distribution of
activity [3]. A single nucleotide polymorphism in the coding
region was found to cause variability in the amino acid present
at position 192, where either glutamine (Q) or arginine (R)
could be present [4,5].
Another polymorphism was identiﬁed in the coding region
that resulted in an amino acid substitution at codon 55 [leucine
(L)/methionine (M)] [6].
The present study was carried out to investigate the impact
of polymorphisms in the PON1 coding region (Q192R and
L55M) on individual sensitivity to OP poisoning.
2. Patients
This work was done after taking acceptance of all patients to
share in the study as well as acceptance of The Ethics
Committee of Ain Shams University. The work has been
carried out in accordance with the code of Ethics of the
World Medical Association (Declaration of Helsinki) for
experiments involving humans. This retrospective study exam-
ined the comprehensive medical, nursing, and intensive care
records of 42 patients admitted to the Poisoning Control
Center Ain-Shams University Hospitals, for acute OP poison-
ing between January andDecember, 2012. Initial diagnoses
were established in all cases based on cholinergic clinical
features, the odor of OP in the gastric contents, history, and
other circumstantial evidence, such as the poison or a label of
an OP-containing product found by relatives. The grouping
of the OP poisoning cases was done depending upon signs
and symptoms as well as their pseudo cholinesterase levels [7]
as following (n= number of patients):
Grade 1 – OP poisoned with no signs and symptoms
(n= 2)
Grade 2 – Diarrhea, vomiting, abdominal pain, giddiness
(n= 9).Grade 3 – Pupillary constriction with above symptoms
(n= 16).
Grade 4 – Pulmonary edema (n= 15).
Grade 5 – Unconsciousness (n= 0).
3. Methods
DNA was extracted from whole blood using a QIAamp Blood
mini-prep Kit (QIAGEN, Germany) according to manufac-
turer’s instructions. Genomic DNA (300 ng) was ampliﬁed in
a ﬁnal volume of 50 ll, containing 10 mM TRIS pH 8.3,
50 mM KCl, 1.5 mM MgCl2, 200 mM each dNTP, 1 ll M of
each primer and 2 U Taq polymerase (all reagents from MBI
Fermentas, St. Leon-Rot, Germany). The thermocycling pro-
cedure (9700 apparatus, Applied Biosystem, USA) consisted
of denaturation at 94 C for 30 s, annealing at 56 C for
1 min, and extension at 72 C for 1 min, repeated for 35 cycles,
followed by a ﬁnal extension at 72 C for 15 min. PCR was
followed by restriction digestion, the nucleotide substitution
corresponding to position 55 (Met/Leu) and 192 (Gln/Arg)
creates an Hsp92II (Hin1II) (Fermentas, Germany, ER1831)
and AlwI (BspPI) (Fermentas, Germany, ER1321) restriction
site. Individuals homozygous for the L allele showed only
the presence of a 384 bp product and those homozygous for
the M allele showed 282 and 102 bp products. In Q192R
polymorphism, individuals homozygous for Q allele had
150 bp and homozygous for the R allele 89 and 61 bp prod-
ucts. Primer sequences, restriction enzymes and PCR products
are listed in Table 1.
3.1. Statistical analysis
Results were analyzed using the Statistical Package of Social
Sciences (SPSS) computer software program, version 21.0
(Chicago, IL, USA). Quantitative data were presented as
mean ± SD for normally distributed data. Qualitative data
were presented in the form of frequencies and percentages.
Differences among groups were tested using Pearson’s
chi-square test (v2). A p value less than 0.05 was considered
statistically signiﬁcant.
4. Results
Among the studied subjects, there were 23.8% smokers and
76.19% were non-smokers. 88% of the cases were poisoned
orally, 7.14% were poisoned by inhalation and 4.76% were
poisoned dermally. Considering the intention of poisoning;
52.38% were poisoned by accident while 47.61% were
poisoned by committing suicide. Delay between poisoning
and diagnosis ranged between 2 and 30 h with a mean ± SD
of 10.05 ± 6.35. Demographic characteristics of the cases are
given in Table 2.
Genotype frequency distribution of PON1 L55M polymor-
phism among different OP poisoning grades (Table 3) revealed
no signiﬁcant difference between the four grades. However, it
was found that grade 4 OP poisoning had a high LM genotype
frequency (3.3%), followed by MM genotype with a frequency
of 33.3% and LL with a frequency of 13.3%. In contrast,
frequency distribution of PON1 Q192R polymorphism
Table 1 Oligonucleotides used as primers for polymerase chain reaction and restriction endonucleases for restriction analysis [32].







Table 2 Demographic characteristics of the OP poisoned
cases.
Characteristic Value
Number of patients 42
Females/Males 21 (50%)/21 (50%)




Smokers/Non-smokers 10 (23.8%)/32 (76.19%)















no signs and symptoms
Diarrhea, vomitin
abdominal pain
LL No. 0 2
% 0% 22.2%
LM No. 2 2
% 100.0% 22.2%
MM No. 0 5
% 0% 55.6%
Total No. 2 9
NS = non-signiﬁcant difference.
Table 4 PON1 Q192R genotype frequency in each OP grade.
Grade of poisoning
1 2




QQ No. 0 5
% 0% 55.6%
QR No. 1 4
% 50.0% 44.4%
RR No. 1 0
% 50.0% 0%
Total No. 2 9
* Signiﬁcant difference.
PON 1 coding gene polymorphisms L55M and Q192R 235(Table 4) showed a highly signiﬁcant (p< 0.001) difference
between different grades of OP poisoning, with grade 4 having
a high QQ genotype frequency, followed by QR, with
frequency distribution of 66.7% and 33.3%, respectively, while
the RR and QR alleles were similarly distributed in grade 1
with a frequency of 50% for each.
5. Discussion
Serum paraoxonase (PON1) is an esterase that is involved in
the detoxiﬁcation of organophosphate insecticides [8,9]. The
pon1 gene contains functional polymorphisms in both the
coding and promoter regions. In the coding region, two
common polymorphism are a glutamine (Q) to arginine (R)
substitution at codon 192 (Q192R) and a leucine (L) to
methionine (M) substitution at position 55 (L55M). In
Q192R polymorphism the exchange of codon CAA to CGA
























236 N.Y.S. Morcos et al.which differ greatly in the rate of hydrolysis of a number of
substrates. Paraoxon is hydrolyzed at a far greater rate by
the R192 isoform compared to the Q192, but some
organophosphates and lactones are hydrolyzed faster by
Q192 [10,11]. L55M polymorphism (exchange of codon TTG
to ATG in exon 3) is correlated with the blood enzyme level,
with isoform L55 associated with higher serum enzymatic
activity. It is not clear whether this is because of a decreased
stability of the M55 alloenzyme and/or because of the linkage
disequilibrium with 107/108 T allele [12,13]. Isoform M55
showed lower stability and loses activity more rapidly and to
a greater extent than the L isoform [14]. This is due to the
key role of L55 in packing in the propeller’s central tunnel,
and of its neighboring residues which ligate calcium ions
[15]. Emerging lines of evidence have shown that functional
polymorphisms in the PON1 gene might play a critical role
in increasing susceptibility to organophosphate toxicity, but
individually published studies showed inconclusive results [9].
The present results suggest a possible relation between QR
genotype and poor OP poisoning prognosis, and also suggest
that the RR genotype might be excluded as a predictor of poor
prognosis. These results are in accordance with Burton et al.
[16], who stated that having one of the two slow metabolism
(Gln/Gln; QQ or Gln/Arg; QR) genotypes is one of the
independent predictors of chronic OP toxicity. The authors
observed that the prevalence of chronic toxicity increased in
a stepwise fashion, which differed according to the PON geno-
type, ranging from 15% (slow metabolism (Gln/Gln; QQ or
Gln/Arg; QR) to 75% (fast metabolism Arg/Arg; RR)).
Meanwhile, the present results revealed that the
distribution of the L55M polymorphism did not differ among
the OP poisoning grades. Comparable observation was
previously reported [9,17,18], elucidating that L/M polymor-
phism at position 55 does not affect catalytic activity, but is
associated with plasma PON1 protein levels, with PON1M55
being linked with low plasma PON1 [17,18]. This may result
primarily from linkage disequilibrium with the low efﬁciency
108T allele of the 108 promoter region polymorphism
[19]. In contrast, the Q192R polymorphism signiﬁcantly affects
the catalytic efﬁciency of PON1. This polymorphism is sub-
strate-dependent, as for example, the PON1R192 alloform
hydrolyzes chlorpyrifos oxon and paraoxon more rapidly than
PON1Q192 in vitro, while both PON1 alloforms hydrolyze
diazoxon with the same efﬁciency [20].
While PON1 has been known for decades to hydrolyze a
number of OP substrates in vitro, evidence of the role played
by this enzyme in modulating the toxicity of OPs in vivo has
emerged only in the past 20 years [9]. Initially, exogenous
PON1 was directly injected into rats or mice to determine
whether increasing plasma PON1 levels would protect against
OP toxicity. Some studies conﬁrmed that administration of
PON1, via different routes, protected animals against the
toxicity of Ops through decreasing the rate of acetyl-
cholinesterase (AChE) inhibition [21–23], suggesting a
potential therapeutic use in OP poisoning, possibly in
combination with other conventional treatments [24].
In accordance with our results about PON1Q/R192 are
various human studies on OPs toxicities, in several countries
under different circumstances, reported that human toxicity
with Ops differed according to their genotypes and PON1
polymorphism. In the Gulf area in 1990–1991, studies investi-
gated PON1 polymorphisms in military personnel, who wereexposed to low levels of sarin, OP insecticides, in addition to
several other biological and chemical agents [25,26]. They
found that PON1R192 homozygotes or PON1Q/R192
heterozygotes were more likely to have neurologic symptoms
than individuals homozygous for PONQ192 [26]. Low activity
of the plasma PON1Q192 isoform also appeared to better cor-
relate with illness than the PON1 genotype or the activity
levels of the PON1R192 genotype [27]. Another study on
South African workers, reported that symptoms of chronic
OP toxicity were signiﬁcantly more likely among subjects with
the QQ or QR genotypes than those with the RR genotype
[28]. A different supporting study is an occupational one on
Brazilian agricultural workers, which conveyed that workers
with homozygotes for PON1Q192 presented with higher
genotoxic effects (as determined by a higher lymphocyte
micronucleus frequency) than other workers [29]. However,
this population of workers was exposed to a large number of
pesticides; among the few OPs, none was a known PON1 sub-
strate. Thus, the signiﬁcance of this ﬁnding is obscure, at best.
In a similar study in India, agricultural workers exposed to
unknown OP insecticides were reported to have higher DNA
damage in lymphocytes if they had low PON1 status (only
identiﬁed as QQ/MM genotypes) [30]. Another study in
Spain investigated the association between PON1 statuses,
OP exposure and thyroid function [31]. Results indicated that
impaired thyroid function in OP-exposed agricultural workers
was greater in individuals with lower PON1 activity.
6. Conclusion
Overall, the human studies available so far provide initial
evidence that low PON1 status may increase susceptibility to
adverse effects of certain OP insecticides. Nevertheless, while
animal studies indicate that PON1 status is an important
determinant of sensitivity to acute toxicity of certain OPs, it
is still uncertain whether it may play a signiﬁcant role at lower
dose levels of exposure.
7. Recommendations
Further studies, with larger sample size, under chronic (instead
of acute) OP exposure would be needed to ascertain individ-
ual’s susceptibility to OPs’ adverse effects upon chronic low
level exposure. Without such conﬁrmatory studies, genetic
testing in the work place to screen for individuals at high risk
for OP-induced adverse health effects would be inconclusive.
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